BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev 2017;11:CD012037. [PMID: 29103210 DOI: 10.1002/14651858.CD012037.pub2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Urbaniak SK, Boguszewska K, Szewczuk M, Kaźmierczak-Barańska J, Karwowski BT. 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development. Molecules 2020;25:E202. [PMID: 31947819 DOI: 10.3390/molecules25010202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Faure M, Bertoldo MJ, Khoueiry R, Bongrani A, Brion F, Giulivi C, Dupont J, Froment P. Metformin in Reproductive Biology. Front Endocrinol (Lausanne) 2018;9:675. [PMID: 30524372 DOI: 10.3389/fendo.2018.00675] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
3 Martis R, Crowther CA, Shepherd E, Alsweiler J, Downie MR, Brown J. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018;8:CD012327. [PMID: 30103263 DOI: 10.1002/14651858.cd012327.pub2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
4 Hegerty CK. The new gestational diabetes: Treatment, evidence and consent. Aust N Z J Obstet Gynaecol 2020;60:482-5. [PMID: 32506466 DOI: 10.1111/ajo.13116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mitric C, Desilets J, Brown RN. Recent advances in the antepartum management of diabetes. F1000Res 2019;8:F1000 Faculty Rev-622. [PMID: 31119029 DOI: 10.12688/f1000research.15795.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 López-Tinoco C, Jiménez-Blázquez JL, Larrán-Escandón L, Roca-Rodríguez MDM, Bugatto F, Aguilar-Diosdado M. Effect of Different Insulin Therapies on Obstetric-Fetal Outcomes. Sci Rep 2019;9:17650. [PMID: 31776421 DOI: 10.1038/s41598-019-54164-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Kharbikar BN, Chendke GS, Desai TA. Modulating the foreign body response of implants for diabetes treatment. Adv Drug Deliv Rev 2021;174:87-113. [PMID: 33484736 DOI: 10.1016/j.addr.2021.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Fernández-Alba JJ, Soto Pazos E, Moreno Cortés R, Vilar Sánchez Á, González Macías C, Castillo Lara M, Moreno Corral L, Sainz Bueno JA. "INTERGROWTH21st vs customized fetal growth curves in the assessment of the neonatal nutritional status: a retrospective cohort study of gestational diabetes". BMC Pregnancy Childbirth 2020;20:139. [PMID: 32131758 DOI: 10.1186/s12884-020-2845-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wei W, Zhang X. Expression of ADP and TNF-α in patients with gestational diabetes mellitus and its relationship with pregnancy outcomes. Exp Ther Med 2020;20:2184-90. [PMID: 32765694 DOI: 10.3892/etm.2020.8952] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 de Wit L, Rademaker D, Voormolen DN, Akerboom BMC, Kiewiet-Kemper RM, Soeters MR, Verwij-Didden MAL, Assouiki F, Schippers DH, Vermeulen MAR, Kuppens SMI, Oosterwerff MM, Zwart JJ, Diekman MJM, Vogelvang TE, Gallas PRJ, Galjaard S, Visser W, Horree N, Klooker TK, Laan R, Heijligenberg R, Huisjes AJM, van Bemmel T, van Meir CA, van den Beld AW, Hermes W, Vidarsdottir S, Veldhuis-Vlug AG, Dullemond RC, Jansen HJ, Sueters M, de Koning EJP, van Laar JOEH, Wouters-van Poppel P, Sanson-van Praag ME, van den Akker ES, Brouwer CB, Hermsen BB, Potter van Loon BJ, van der Heijden OWH, de Galan BE, van Leeuwen M, Wijbenga JAM, de Boer K, van Bon AC, van der Made FW, Eskes SA, Zandstra M, van Houtum WH, Braams-Lisman BAM, Daemen-Gubbels CRGM, Wouters MGAJ, IJzerman RG, Mensing van Charante NA, Zwertbroek R, Bosmans JE, Evers IM, Mol BW, de Valk HW, Groenendaal F, Naaktgeboren CA, Painter RC, deVries JH, Franx A, van Rijn BB. SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial. BMJ Open 2019;9:e029808. [PMID: 31427334 DOI: 10.1136/bmjopen-2019-029808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev 2017;11:CD012037. [PMID: 29103210 DOI: 10.1002/14651858.CD012037.pub2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
12 Tieu J, Coat S, Hague W, Middleton P, Shepherd E. Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes. Cochrane Database Syst Rev 2017;10:CD007724. [PMID: 29045765 DOI: 10.1002/14651858.CD007724.pub3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Bröms G, Einarsdóttir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Kieler H, Li J, Leinonen MK, Gulseth HL, Tran D, Yu Y, Zoega H, Odsbu I. Antidiabetic medication use during pregnancy: an international utilization study. BMJ Open Diabetes Res Care 2019;7:e000759. [PMID: 31798900 DOI: 10.1136/bmjdrc-2019-000759] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
14 Xu YXZ, Xi S, Qian X. Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus. J Diabetes Res 2019;2019:9182595. [PMID: 31886289 DOI: 10.1155/2019/9182595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Priya G, Kalra S. Metformin in the management of diabetes during pregnancy and lactation. Drugs Context 2018;7:212523. [PMID: 29942340 DOI: 10.7573/dic.212523] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
16 Pedersen ML. Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken. Int J Circumpolar Health 2019;78:1709257. [PMID: 31996108 DOI: 10.1080/22423982.2019.1709257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Guo L, Ma J, Tang J, Hu D, Zhang W, Zhao X. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis. J Diabetes Res 2019;2019:9804708. [PMID: 31781670 DOI: 10.1155/2019/9804708] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
18 Rodenstein MS, Bianco ME, Ramchal MU, Murias M, Silton RL, Josefson JL. Long-term follow-up of children with in utero exposure to sulfonylurea medications. Obes Sci Pract 2021;7:487-93. [PMID: 34401206 DOI: 10.1002/osp4.488] [Reference Citation Analysis]
19 Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, Aagaard K, Thornburg KL, Catalano PM, Galan HL, Hay WW Jr, Frias AE, Shankar K, Simmons RA, Moses RG, Sacks DA, Loeken MR. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 2018;219:367.e1-7. [PMID: 29959933 DOI: 10.1016/j.ajog.2018.06.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
20 Fagninou A, Nekoua MP, Sossou D, Moutairou K, Fievet N, Yessoufou A. Th2-Immune Polarizing and Anti-Inflammatory Properties of Insulin Are Not Effective in Type 2 Diabetic Pregnancy. J Immunol Res 2020;2020:2038746. [PMID: 32626786 DOI: 10.1155/2020/2038746] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Tieu J, Shepherd E, Middleton P, Crowther CA. Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. Cochrane Database Syst Rev 2017;8:CD010211. [PMID: 28836274 DOI: 10.1002/14651858.CD010211.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Tieu J, McPhee AJ, Crowther CA, Middleton P, Shepherd E. Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health. Cochrane Database Syst Rev 2017;8:CD007222. [PMID: 28771289 DOI: 10.1002/14651858.CD007222.pub4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
23 Kong CM, Subramanian A, Biswas A, Stunkel W, Chong YS, Bongso A, Fong CY. Changes in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton's Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes Mellitus. Stem Cell Rev Rep 2019;15:415-26. [PMID: 30645713 DOI: 10.1007/s12015-019-9872-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
24 Wexler DJ, Powe CE, Barbour LA, Buchanan T, Coustan DR, Corcoy R, Damm P, Dunne F, Feig DS, Ferrara A, Harper LM, Landon MB, Meltzer SJ, Metzger BE, Roeder H, Rowan JA, Sacks DA, Simmons D, Umans JG, Catalano PM. Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Obstet Gynecol 2018;132:496-505. [PMID: 29995731 DOI: 10.1097/AOG.0000000000002726] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 12.3] [Reference Citation Analysis]
25 Jayasingh S Sr, Nanda S, Misra S, Baliarsinha A, Das S, Patil A. Comparison of Fetomaternal Outcomes in Patients With Gestational Diabetes Mellitus Treated With Insulin Versus Acarbose: Results of a Prospective, Open Label, Controlled Study. Cureus 2020;12:e12283. [PMID: 33403188 DOI: 10.7759/cureus.12283] [Reference Citation Analysis]
26 Zhang Z, Zhao H, Wang A. Oleuropein alleviates gestational diabetes mellitus by activating AMPK signaling. Endocr Connect 2021;10:45-53. [PMID: 33289688 DOI: 10.1530/EC-20-0466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]